Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
--------
Question: Paragraph: Three of the other five patients are in either a serious or a critical condition in hospital, while the remaining two have mild symptoms, the United Nations health agency said in a disease outbreak update. H7N9 bird flu emerged last year in China and has infected around 150 people so far there and in Taiwan and Hong Kong, killing at least 46 of them. The latest death was a 38-year-old man from China’s Fujian Province who became ill with H7N9 on January 3, was admitted to hospital on January 8 but died 2 days later. He had underlying illnesses, including tuberculosis and pneumoconiosis. China’s state news agency Xinhua reported another death from H7N9 in the southwestern Guizhou province on Monday, but this has yet to be confirmed by the WHO. A 65-year-old man infected with H7N9 also died in Hong Kong, the government said on Monday. The WHO reiterated there is no evidence as yet of any easy or sustained person-to-person transmission of the strain, and that the source of the human infections is still under investigation. Researchers in the United States said last month that while it is not impossible that H7N9 could become easily transmissible between people, it would need to undergo multiple mutations to do that. Scientists around the world are keeping a watchful eye, on alert for any sign the virus might develop that potential and start to spread rapidly. Claim: Death toll from new China bird flu rises: WHO.

Answer: Six more people in China have been confirmed as infected with the new H7N9 strain of bird flu and one of them has died, the World Health Organisation (WHO) said on Monday.


Question: Paragraph: U.S. District Judge George Caram Steeh in Michigan concluded Wednesday it’s in the public interest to deny the preliminary injunction sought by William Husel. The Columbus-area Mount Carmel Health System fired the intensive care doctor after concluding he ordered excessive painkillers for dozens of patients who died. Husel has pleaded not guilty in the resulting criminal case. His pending lawsuit against Mount Carmel’s parent company, Trinity Health Corporation, and its insurer argues his ability to defend himself is hurt if they won’t cover his legal costs in the criminal case as happened in dozens of related civil cases. The judge concluded the public interest supported denying the preliminary injunction “to protect THC’s Catholic principles on end of life issues, to comport with public policy that liability insurance does not exist to relieve wrongdoers for intentional criminal conduct, and to fulfill the court’s obligation to read the insurance contract by its plain and unambiguous terms.”  A spokeswoman for Mount Carmel said by email that it and Livonia, Michigan-based Trinity Health, are pleased with the decision and focusing on patient care. Husel’s lawyer in the matter called the decision disappointing and accused those health care systems of misleading the public. “Mount Carmel and Trinity both know that Dr. Husel’s care was entirely appropriate and did not cause harm to any patient, and they should be standing up for their employees and defending them against all baseless allegations,” attorney Adam Ford of Ford O’Brien LLP said in an email. In a separate defamation lawsuit against Mount Carmel and Trinity, Husel contends the patients died because of their illnesses, not the drugs he ordered. Claim: Judge won’t compel health system to fund doctor’s defense.

Answer: A federal judge declined for now to compel a Michigan-based health system to advance legal costs for a doctor’s defense against murder charges in the deaths of 25 Ohio hospital patients.


Question: Paragraph: Inflammation in arteries has been associated with an increased risk of stroke. Inflammation and emboli, or small blood clots, were significantly reduced in patients treated with 80 milligrams of Lipitor compared with those who received 10 mg of the drug each day for 12 weeks, said researchers, who presented the data at the American College of Cardiology scientific meeting on Monday. The study divided 40 patients with diseased carotid arteries into the two groups. The artery was examined for changes in inflammation at six weeks and 12 weeks using a unique contrast agent with high-resolution magnetic resonance imaging (MRI). While the 80 mg Lipitor, known generically as atorvastatin, reduced inflammation, researchers appeared even more enthusiastic about the technique used to measure the results. The arteries were viewed using Ultra Small Particles of Iron Oxide, or USPIO-enhanced, high-resolution MRI. “The real star of this study is this new way of imaging, which allows you to zero in on what is actually going on in these arteries,” said Dr Jonathan Gillard, one of the study’s lead researchers. The study demonstrates that if you treat patients who have inflammation of the carotid artery with “a high dose of atorvastatin, you substantially reduce the amount of inflammation and risk of stroke, whereas low dose atorvastatin does not reduce risk,” Gillard said. “Thanks to this imaging technique, we can now figure out which patients need the aggressive treatment before we begin our therapy,” he added. Lipitor, which lowers levels of LDL, or bad, cholesterol in the blood, is the world’s top-selling prescription medicine with some $12 billion in annual sales. Claim: High dose Lipitor reduces artery inflammation: study.

Answer:
High doses of Pfizer Inc’s Lipitor was more effective than low doses of the cholesterol fighter in reducing arterial inflammation in patients with carotid artery disease, according to a small, 12-week study.